SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-13-481388
Filing Date
2013-12-23
Accepted
2013-12-20 19:47:02
Documents
3
Period of Report
2013-10-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K d646943d8ka.htm 8-K/A 18802
2 EX-99.1 d646943dex991.htm EX-99.1 214037
3 EX-99.2 d646943dex992.htm EX-99.2 188352
  Complete submission text file 0001193125-13-481388.txt   422302
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35952 | Film No.: 131292935
SIC: 2834 Pharmaceutical Preparations